Plant glyco-biotechnology on the way to synthetic biology

Frontiers in Plant Science

Volumn 5, Issue OCT, 2014, Pages

  Loos, Andreas ^a   Steinkellner, Herta ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

CTS; Glycoengineering; Glycosyltransferase; Plant; Sub Golgi targeting

Indexed keywords

EID: 84907753100     PISSN: None     EISSN: 1664462X     Source Type: Journal    
DOI: 10.3389/fpls.2014.00523     Document Type: Review

References (99)

1. Aebi, M. (2013). N-linked protein glycosylation in the ER. Biochim. Biophys. Acta 1833, 2430-2437. doi: 10.1016/j.bbamcr.2013.04.001
2. Aggarwal, R. S. (2014). What's fueling the biotech engine-2012 to 2013. Nat. Biotechnol. 32, 32-39. doi: 10.1038/nbt.2794
3. Altmann, F., Fabini, G., Ahorn, H., and Wilson, I. B. (2001). Genetic model organisms in the study of N-glycans. Biochimie 83, 703-712. doi: 10.1016/S0300-9084(01)01297-4
4. Altmann, F., Staudacher, E., Wilson, I. B., and Marz, L. (1999). Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconj. J. 16, 109-123. doi: 10.1023/A:1026488408951
5. Bakker, H., Bardor, M., Molthoff, J. W., Gomord, V., Elbers, I., Stevens, L. H.,et al. (2001). Galactose-extended glycans of antibodies produced by transgenic plants. Proc. Natl. Acad. Sci. U.S.A. 98, 2899-2904. doi: 10.1073/pnas.031419998
6. Bakker, H., Rouwendal, G. J., Karnoup, A. S., Florack, D. E., Stoopen, G. M., Helsper, J. P.,et al. (2006). An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc. Natl. Acad. Sci. U.S.A. 103, 7577-7582. doi: 10.1073/pnas.0600879103
7. Bardor, M., Faveeuw, C., Fitchette, A. C., Gilbert, D., Galas, L., Trottein, F.,et al. (2003). Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose. Glycobiology 13, 427-434. doi: 10.1093/glycob/cwg024
8. Bendandi, M., Marillonnet, S., Kandzia, R., Thieme, F., Nickstadt, A., Herz, S.,et al. (2010). Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Ann. Oncol. 21, 2420-2427. doi: 10.1093/annonc/mdq256
9. Blizzard, R. M. (2012). History of growth hormone therapy. Indian J. Pediatr. 79, 87-91. doi: 10.1007/s12098-011-0609-4
10. Blundell, J. (1818). Experiments on the transfusion of blood by the syringe. Med. Chir. Trans. 9, 56-92.
11. Bosch, D., Castilho, A., Loos, A., Schots, A., and Steinkellner, H. (2013). N-Glycosylation of plant-produced recombinant proteins. Curr. Pharm. Des. 19, 5503-5512. doi: 10.2174/1381612811319310006
12. Campbell, C. T., and Yarema, K. J. (2005). Large-scale approaches for glycobiology. Genome Biol. 6:236. doi: 10.1186/gb-2005-6-11-236
13. Carver, J. P., Grey, A. A., Winnik, F. M., Hakimi, J., Ceccarini, C., and Atkinson, P. H. (1981). Determination of the structure of four glycopeptides from hen ovalbumin using 360-MHz proton magnetic resonance spectroscopy. Biochemistry 20, 6600-6606. doi: 10.1021/bi00526a013
14. Castilho, A., Gattinger, P., Grass, J., Jez, J., Pabst, M., Altmann, F.,et al. (2011). N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 21, 813-823. doi: 10.1093/glycob/cwr009
15. Castilho, A., Neumann, L., Daskalova, S., Mason, H. S., Steinkellner, H., Altmann, F.,et al. (2012). Engineering of sialylated mucin-type O-glycosylation in plants. J. Biol. Chem. 287, 36518-36526. doi: 10.1074/jbc.M112.402685
16. Castilho, A., Neumann, L., Gattinger, P., Strasser, R., Vorauer-Uhl, K., Sterovsky, T.,et al. (2013). Generation of biologically active multi-sialylated recombinant human EPOFc in plants. PLoS ONE 8:e54836. doi: 10.1371/journal.pone.0054836
17. Castilho, A., Pabst, M., Leonard, R., Veit, C., Altmann, F., Mach, L.,et al. (2008). Construction of a functional CMP-sialic acid biosynthesis pathway in Arabidopsis. Plant Physiol. 147, 331-339. doi: 10.1104/pp.108.117572
18. Castilho, A., and Steinkellner, H. (2012). Glyco-engineering in plants to produce human-like N-glycan structures. Biotechnol. J. 7, 1088-1098. doi: 10.1002/biot.201200032
19. Castilho, A., Strasser, R., Stadlmann, J., Grass, J., Jez, J., Gattinger, P.,et al. (2010). In planta protein sialylation through overexpression of the respective mammalian pathway. J. Biol. Chem. 285, 15923-15930. doi: 10.1074/jbc.M109.088401
20. Cox, K. M., Sterling, J. D., Regan, J. T., Gasdaska, J. R., Frantz, K. K., Peele, C. G.,et al. (2006). Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat. Biotechnol. 24, 1591-1597. doi: 10.1038/nbt1260
21. Defense Advanced Research Projects Agency [DARPA]. (2012). DARPA Produces Over 10 Million Doses of H1N1 Vaccine Candidate in One Month. Available at: http://www.darpa.mil/NewsEvents/Releases/2012/07/25.aspx(accessed July 7, 2014).
22. Dirnberger, D., Steinkellner, H., Abdennebi, L., Remy, J. J., and Van De Wiel, D. (2001). Secretion of biologically active glycoforms of bovine follicle stimulating hormone in plants. Eur. J. Biochem. 268, 4570-4579. doi: 10.1046/j.1432-1327.2001.02384.x
23. Eibl, M. M. (2008). History of immunoglobulin replacement. Immunol. Allergy Clin. North Am. 28, 737-764. doi: 10.1016/j.iac.2008.06.004
24. Elvin, J. G., Couston, R. G., and Van Der Walle, C. F. (2013). Therapeutic antibodies: market considerations, disease targets and bioprocessing. Int. J. Pharm. 440, 83-98. doi: 10.1016/j.ijpharm.2011.12.039
25. Essl, D., Dirnberger, D., Gomord, V., Strasser, R., Faye, L., Glossl, J.,et al. (1999). The N-terminal 77 amino acids from tobacco N-acetylglucosaminyltransferase I are sufficient to retain a reporter protein in the Golgi apparatus ofNicotiana benthamiana cells. FEBS Lett. 453, 169-173. doi: 10.1016/S0014-5793(99)00712-7
26. Fanata, W. I. D., Lee, K. H., Son, B. H., Yoo, J. Y., Harmoko, R., Ko, K. S.,et al. (2013). N-glycan maturation is crucial for cytokinin-mediated development and cellulose synthesis in Oryza sativa. Plant J. 73, 966-979. doi: 10.1111/tpj.12087
27. Felts, J. H. (2000). Richard lower: anatomist and physiologist. Ann. Intern. Med. 132, 420-423. doi: 10.7326/0003-4819-132-5-200003070-00023
28. Fitchette, A. C., Cabanes-Macheteau, M., Marvin, L., Martin, B., Satiat-Jeunemaitre, B., Gomord, V.,et al. (1999). Biosynthesis and immunolocalization of Lewis a-containing N-glycans in the plant cell. Plant Physiol. 121, 333-344. doi: 10.1104/pp.121.2.333
29. Fitchette-Laine, A. C., Gomord, V., Cabanes, M., Michalski, J. C., Saint Macary, M., Foucher, B.,et al. (1997). N-glycans harboring the Lewis a epitope are expressed at the surface of plant cells. Plant J. 12, 1411-1417. doi: 10.1046/j.1365-313x.1997.12061411.x
30. Forthal, D. N., Gach, J. S., Landucci, G., Jez, J., Strasser, R., Kunert, R.,et al. (2010). Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12. J. Immunol. 185, 6876-6882. doi: 10.4049/jimmunol.1002600
31. Frey, A. D., Karg, S. R., and Kallio, P. T. (2009). Expression of rat beta(1,4)-N-acetylglucosaminyltransferase III inNicotiana tabacum remodels the plant-specific N-glycosylation. Plant Biotechnol. J. 7, 33-48. doi: 10.1111/j.1467-7652.2008.00370.x
32. Gleba, Y. Y., Tuse, D., and Giritch, A. (2014). Plant viral vectors for delivery by Agrobacterium. Curr. Top. Microbiol. Immunol. 375, 155-192. doi: 10.1007/82_2013_352
33. Goodman, J. L. (2014). Studying "Secret Serums" - toward safe, effective ebola treatments. N. Engl. J. Med. 371, 1086-1089. doi: 10.1056/NEJMp1409817
34. Grabowski, G. A., Golembo, M., and Shaaltiel, Y. (2014). Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology. Mol. Genet. Metab. 112, 1-8. doi: 10.1016/j.ymgme.2014.02.011
35. Helenius, A., and Aebi, M. (2001). Intracellular functions of N-linked glycans. Science 291, 2364-2369. doi: 10.1126/science.291.5512.2364
36. Hiatt, A., Bohorova, N., Bohorov, O., Goodman, C., Kim, D., Pauly, M. H.,et al. (2014). Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy. Proc. Natl. Acad. Sci. U.S.A. 111, 5992-5997. doi: 10.1073/pnas.1402458111
37. Jacobs, P. P., and Callewaert, N. (2009). N-glycosylation engineering of biopharmaceutical expression systems. Curr. Mol. Med. 9, 774-800. doi: 10.2174/156652409789105552
38. Jefferis, R. (2009). Glycosylation as a strategy to improve antibody-based therapeutics. Nat. Rev. Drug Discov. 8, 226-234. doi: 10.1038/nrd2804
39. Jiang, L. W., and Rogers, J. C. (1998). Integral membrane protein sorting to vacuoles in plant cells: evidence for two pathways. J. Cell Biol. 143, 1183-1199. doi: 10.1083/jcb.143.5.1183
40. Kajiura, H., Okamoto, T., Misaki, R., Matsuura, Y., and Fujiyama, K. (2012). Arabidopsis beta1,2-xylosyltransferase: substrate specificity and participation in the plant-specific N-glycosylation pathway. J. Biosci. Bioeng. 113, 48-54. doi: 10.1016/j.jbiosc.2011.09.011
41. Karg, S. R., Frey, A. D., and Kallio, P. T. (2010). Reduction of N-linked xylose and fucose by expression of rat beta1,4-N-acetylglucosaminyltransferase III in tobacco BY-2 cells depends on Golgi enzyme localization domain and genetic elements used for expression. J. Biotechnol. 146, 54-65. doi: 10.1016/j.jbiotec.2010.01.005
42. Koprivova, A., Stemmer, C., Altmann, F., Hoffmann, A., Kopriva, S., Gorr, G.,et al. (2004). Targeted knockouts ofPhyscomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol. J. 2, 517-523. doi: 10.1111/j.1467-7652.2004.00100.x
43. Li, H., Sethuraman, N., Stadheim, T. A., Zha, D., Prinz, B., Ballew, N.,et al. (2006). Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat. Biotechnol. 24, 210-215. doi: 10.1038/nbt1178
44. Liebminger, E., Veit, C., Pabst, M., Batoux, M., Zipfel, C., Altmann, F.,et al. (2011). Beta-N-acetylhexosaminidases HEXO1 and HEXO3 are responsible for the formation of paucimannosidic N-glycans in Arabidopsis thaliana. J. Biol. Chem. 286, 10793-10802. doi: 10.1074/jbc.M110.178020
45. Loos, A., and Steinkellner, H. (2012). IgG-Fc glycoengineering in non-mammalian expression hosts. Arch. Biochem. Biophys. 526, 167-173. doi: 10.1016/j.abb.2012.05.011
46. Lozano-Juste, J., and Cutler, S. R. (2014). Plant genome engineering in full bloom. Trends Plant Sci. 19, 284-287. doi: 10.1016/j.tplants.2014.02.014
47. Matsuo, K., and Matsumura, T. (2011). Deletion of fucose residues in plant N-glycans by repression of the GDP-mannose 4,6-dehydratase gene using virus-induced gene silencing and RNA interference. Plant Biotechnol. J. 9, 264-281. doi: 10.1111/j.1467-7652.2010.00553.x
48. Meuris, L., Santens, F., Elson, G., Festjens, N., Boone, M., Dos Santos, A.,et al. (2014). GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins. Nat. Biotechnol. 32, 485-489. doi: 10.1038/nbt.2885
49. Nagels, B., Van Damme, E. J., Callewaert, N., and Weterings, K. (2012a). Introduction of tri-antennary N-glycans inArabidopsis thaliana plants. Plant Sci. 185-186, 161-168. doi: 10.1016/j.plantsci.2011.10.002
50. Nagels, B., Van Damme, E. J., Callewaert, N., Zabeau, L., Tavernier, J., Delanghe, J. R.,et al. (2012b). Biologically active, magnICON(®)-expressed EPO-Fc from stably transformed Nicotiana benthamiana plants presenting tetra-antennary N-glycan structures. J. Biotechnol. 160, 242-250. doi: 10.1016/j.jbiotec.2012.03.003
51. Nagels, B., Van Damme, E. J., Pabst, M., Callewaert, N., and Weterings, K. (2011). Production of complex multiantennary N-glycans in Nicotiana benthamiana plants. Plant Physiol. 155, 1103-1112. doi: 10.1104/pp.110.168773
52. Narasimhan, S. (1982). Control of glycoprotein synthesis. UDP-GlcNAc:glycopeptide beta 4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in beta 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides. J. Biol. Chem. 257, 10235-10242.
53. Ohtsubo, K., and Marth, J. D. (2006). Glycosylation in cellular mechanisms of health and disease. Cell 126, 855-867. doi: 10.1016/j.cell.2006.08.019
54. Oikawa, A., Lund, C. H., Sakuragi, Y., and Scheller, H. V. (2013). Golgi-localized enzyme complexes for plant cell wall biosynthesis. Trends Plant Sci. 18, 49-58. doi: 10.1016/j.tplants.2012.07.002
55. Pagny, S., Bouissonnie, F., Sarkar, M., Follet-Gueye, M. L., Driouich, A., Schachter, H.,et al. (2003). Structural requirements for Arabidopsis beta1,2-xylosyltransferase activity and targeting to the Golgi. Plant J. 33, 189-203. doi: 10.1046/j.0960-7412.2002.01604.x
56. Palacpac, N. Q., Yoshida, S., Sakai, H., Kimura, Y., Fujiyama, K., Yoshida, T.,et al. (1999). Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proc. Natl. Acad. Sci. U.S.A. 96, 4692-4697. doi: 10.1073/pnas.96.8.4692
57. Pandhal, J., and Wright, P. C. (2010). N-Linked glycoengineering for human therapeutic proteins in bacteria. Biotechnol. Lett. 32, 1189-1198. doi: 10.1007/s10529-010-0289-6
58. Parsons, J., Altmann, F., Arrenberg, C. K., Koprivova, A., Beike, A. K., Stemmer, C.,et al. (2012). Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-typical carbohydrate determinants. Plant Biotechnol. J. 10, 851-861. doi: 10.1111/j.1467-7652.2012.00704.x
59. Ratner, M. (2014). Genentech's glyco-engineered antibody to succeed Rituxan. Nat. Biotechnol. 32, 6-7. doi: 10.1038/nbt0114-6b
60. Rivera, A. M., Strauss, K. W., Van Zundert, A., and Mortier, E. (2005). The history of peripheral intravenous catheters: how little plastic tubes revolutionized medicine. Acta Anaesthesiol. Belg. 56, 271-282.
61. Roth, J., Zuber, C., Park, S., Jang, I., Lee, Y., Kysela, K. G.,et al. (2010). Protein N-glycosylation, protein folding, and protein quality control. Mol. Cells 30, 497-506. doi: 10.1007/s10059-010-0159-z
62. Rouwendal, G. J., Wuhrer, M., Florack, D. E., Koeleman, C. A., Deelder, A. M., Bakker, H.,et al. (2007). Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III. Glycobiology 17, 334-344. doi: 10.1093/glycob/cwl078
63. Saint-Jore-Dupas, C., Nebenfuhr, A., Boulaflous, A., Follet-Gueye, M. L., Plasson, C., Hawes, C.,et al. (2006). PlantN-glycan processing enzymes employ different targeting mechanisms for their spatial arrangement along the secretory pathway. Plant Cell 18, 3182-3200. doi: 10.1105/tpc.105.036400
64. Sarrion-Perdigones, A., Vazquez-Vilar, M., Palaci, J., Castelijns, B., Forment, J., Ziarsolo, P.,et al. (2013). GoldenBraid 2.0: a comprehensive DNA assembly framework for plant synthetic biology. Plant Physiol. 162, 1618-1631. doi: 10.1104/pp.113.217661
65. Schähs, M., Strasser, R., Stadlmann, J., Kunert, R., Rademacher, T., and Steinkellner, H. (2007). Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol. J. 5, 657-663. doi: 10.1111/j.1467-7652.2007.00273.x
66. Schneider, J. D., Marillonnet, S., Castilho, A., Gruber, C., Werner, S., Mach, L.,et al. (2014). Oligomerization status influences subcellular deposition and glycosylation of recombinant butyrylcholinesterase in Nicotiana benthamiana. Plant Biotechnol. J. 12, 832-839. doi: 10.1111/pbi.12184
67. Schoberer, J., Liebminger, E., Botchway, S. W., Strasser, R., and Hawes, C. (2013). Time-resolved fluorescence imaging reveals differential interactions of N-glycan processing enzymes across the Golgi stack in planta. Plant Physiol. 161, 1737-1754. doi: 10.1104/pp.112.210757
68. Schoberer, J., Runions, J., Steinkellner, H., Strasser, R., Hawes, C., and Osterrieder, A. (2010). Sequential depletion and acquisition of proteins during Golgi stack disassembly and reformation. Traffic 11, 1429-1444. doi: 10.1111/j.1600-0854.2010.01106.x
69. Schoberer, J., and Strasser, R. (2011). Sub-compartmental organization of Golgi-resident N-glycan processing enzymes in plants. Mol. Plant 4, 220-228. doi: 10.1093/mp/ssq082
70. Schoberer, J., Vavra, U., Stadlmann, J., Hawes, C., Mach, L., Steinkellner, H.,et al. (2009). Arginine/lysine residues in the cytoplasmic tail promote ER export of plant glycosylation enzymes. Traffic 10, 101-115. doi: 10.1111/j.1600-0854.2008.00841.x
71. Schuster, M., Umana, P., Ferrara, C., Brünker, P., Gerdes, C., Waxenecker, G.,et al. (2005). Improved effector functions of a therapeutic monoclonal lewis Y-specific antibody by glycoform engineering. Cancer Res. 65, 7934-7941.
72. Shin, Y. J., Chong, Y. J., Yang, M. S., and Kwon, T. H. (2011). Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure. Plant Biotechnol. J. 9, 1109-1119. doi: 10.1111/j.1467-7652.2011.00636.x
73. Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M.,et al. (2003). The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 278, 3466-3473. doi: 10.1074/jbc.M210665200
74. Solá, R. J., and Griebenow, K. (2010). Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs 24, 9-21. doi: 10.2165/11530550-000000000-00000
75. Sourrouille, C., Marquet-Blouin, E., D'Aoust, M. A., Kiefer-Meyer, M. C., Seveno, M., Pagny-Salehabadi, S.,et al. (2008). Down-regulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol. J. 6, 702-721. doi: 10.1111/j.1467-7652.2008.00353.x
76. Staudacher, E., Dalik, T., Wawra, P., Altmann, F., and Marz, L. (1995). Functional purification and characterization of a GDP-fucose: beta-N-acetylglucosamine (Fuc to Asn linked GlcNAc) alpha 1,3-fucosyltransferase from mung beans. Glycoconj. J. 12, 780-786. doi: 10.1007/BF00731239
77. Stoger, E., Fischer, R., Moloney, M., and Ma, J. K. (2014). Plant molecular pharming for the treatment of chronic and infectious diseases. Annu. Rev. Plant Biol. 65, 743-768. doi: 10.1146/annurev-arplant-050213-035850
78. Strasser, R., Altmann, F., Glössl, J., and Steinkellner, H. (2004a). Unaltered complex N-glycan profiles in Nicotiana benthamiana despite drastic reduction of beta1,2- N-acetylglucosaminyltransferase I activity. Glycoconj. J. 21, 275-282. doi: 10.1023/B:GLYC.0000045099.29038.04
79. Strasser, R., Altmann, F., Mach, L., Glössl, J., and Steinkellner, H. (2004b). Generation of Arabidopsis thalianaplants with complex N-glycans lacking beta1,2-linked xylose and core alpha1,3-linked fucose. FEBS Lett. 561, 132-136. doi: 10.1016/S0014-5793(04)00150-4
80. Strasser, R., Bondili, J. S., Schoberer, J., Svoboda, B., Liebminger, E., Glossl, J.,et al. (2007a). Enzymatic properties and subcellular localization of Arabidopsis beta-N-acetylhexosaminidases. Plant Physiol. 145, 5-16. doi: 10.1104/pp.107.101162
81. Strasser, R., Bondili, J. S., Vavra, U., Schoberer, J., Svoboda, B., Glossl, J.,et al. (2007b). A unique beta1,3-galactosyltransferase is indispensable for the biosynthesis of N-glycans containing Lewis a structures inArabidopsis thaliana. Plant Cell 19, 2278-2292. doi: 10.1105/tpc.107.052985
82. Strasser, R., Castilho, A., Stadlmann, J., Kunert, R., Quendler, H., Gattinger, P.,et al. (2009). Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile. J. Biol. Chem. 284, 20479-20485. doi: 10.1074/jbc.M109.014126
83. Strasser, R., Stadlmann, J., Schähs, M., Stiegler, G., Quendler, H., Mach, L.,et al. (2008). Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-likeN-glycan structure. Plant Biotechnol. J. 6, 392-402. doi: 10.1111/j.1467-7652.2008.00330.x
84. Uliana, A. S., Giraudo, C. G., and Maccioni, H. J. (2006). Cytoplasmic tails of SialT2 and GalNAcT impose their respective proximal and distal Golgi localization. Traffic 7, 604-612. doi: 10.1111/j.1600-0854.2006.00413.x
85. Umana, P., Jean-Mairet, J., Moudry, R., Amstutz, H., and Bailey, J. E. (1999). Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat. Biotechnol. 17, 176-180. doi: 10.1038/6179
86. van Dussen, L., Zimran, A., Akkerman, E. M., Aerts, J. M., Petakov, M., Elstein, D.,et al. (2013). Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease. Blood Cells Mol. Dis. 50, 206-211. doi: 10.1016/j.bcmd.2012.11.001
87. Varki, A. (1993). Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3, 97-130. doi: 10.1093/glycob/3.2.97
88. Varki, A. (2006). Nothing in glycobiology makes sense, except in the light of evolution. Cell 126, 841-845. doi: 10.1016/j.cell.2006.08.022
89. Vézina, L. P., Faye, L., Lerouge, P., D'Aoust, M. A., Marquet-Blouin, E., Burel, C.,et al. (2009). Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol. J. 7, 442-455. doi: 10.1111/j.1467-7652.2009.00414.x
90. Von Schaewen, A., Sturm, A., O'Neill, J., and Chrispeels, M. J. (1993). Isolation of a mutant Arabidopsis plant that lacks N-acetyl glucosaminyl transferase-I and is unable to synthesize golgi-modified complex N-linked glycans. Plant Physiol. 102, 1109-1118. doi: 10.1104/pp.102.4.1109
91. Walsh, G. (2010). Biopharmaceutical benchmarks 2010. Nat. Biotechnol. 28, 917-924. doi: 10.1038/nbt0910-917
92. Weber, E., Gruetzner, R., Werner, S., Engler, C., and Marillonnet, S. (2011). Assembly of designer TAL effectors by Golden Gate cloning. PLoS ONE 6:e19722. doi: 10.1371/journal.pone.0019722
93. Wee, E. G., Sherrier, D. J., Prime, T. A., and Dupree, P. (1998). Targeting of active sialyltransferase to the plant Golgi apparatus. Plant Cell 10, 1759-1768. doi: 10.1105/tpc.10.10.1759
94. Wilson, I. B., Zeleny, R., Kolarich, D., Staudacher, E., Stroop, C. J., Kamerling, J. P.,et al. (2001). Analysis of Asn-linked glycans from vegetable foodstuffs: widespread occurrence of Lewis a, core alpha1,3-linked fucose and xylose substitutions. Glycobiology 11, 261-274. doi: 10.1093/glycob/11.4.261
95. www.federalgrants.com. (2012). Butyrylcholinesterase Expression in Plants Federal Grant. Available at:http://www.federalgrants.com/Butyrylcholinesterase-Expression-in-Plants-33798.html [accessed July 7, 2014].
96. Yamane-Ohnuki, N., Kinoshita, S., Inoue-Urakubo, M., Kusunoki, M., Iida, S., Nakano, R.,et al. (2004). Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnol. Bioeng. 87, 614-622. doi: 10.1002/bit.20151
97. Zeitlin, L., Bohorov, O., Bohorova, N., Hiatt, A., Kim, D. H., Pauly, M. H.,et al. (2013). Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model. MAbs 5, 263-269. doi: 10.4161/mabs.23281
98. Zeitlin, L., Pettitt, J., Scully, C., Bohorova, N., Kim, D., Pauly, M.,et al. (2011). Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proc. Natl. Acad. Sci. U.S.A. 108, 20690-20694. doi: 10.1073/pnas.1108360108
99. Zimran, A., Brill-Almon, E., Chertkoff, R., Petakov, M., Blanco-Favela, F., Munoz, E. T.,et al. (2011). Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood 118, 5767-5773. doi: 10.1182/blood-2011-07-366955